Segment Information (Tables)

6 Months Ended

Dec. 31, 2018

Segment Reporting [Abstract]

Schedule of segment performance measures

Six months Ended December 31, 2018 and 2017:

	Human  Health			Pharmaceutical  Ingredients		Performance Chemicals		Unallocated  Corporate			Consolidated  Totals
2018
Net sales	$	165,827		$	80,890	$	81,337	$	-		$	328,054
Gross profit		19,298			13,247		16,981		-			49,526
(Loss) income before income taxes		(23,643	)		5,719		9,173		(32,154	)		(40,905	)
2017
Net sales	$	209,481		$	70,205	$	76,798	$	-		$	356,484
Gross profit		47,545			10,221		16,187		-			73,953
Income (loss) before income taxes		7,314			2,808		7,422		(15,905	)		1,639

Three months Ended December 31, 2018 and 2017:

	Human  Health			Pharmaceutical  Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2018
Net sales	$	84,981		$	42,042	$	36,626	$	-		$	163,649
Gross profit		10,822			6,353		6,871		-			24,046
(Loss) income before income taxes		(10,596	)		2,321		3,245		(16,780	)		(21,810	)
2017
Net sales	$	103,466		$	33,629	$	34,134	$	-		$	171,229
Gross profit		22,898			4,381		6,691		-			33,970
Income (loss) before income taxes		2,288			577		2,477		(5,841	)		(499	)